This upregulation of miR-122 is positively correlated with the degree of inflammation and fibrosis and serves as a valuable indicator of NAFLD severity in various stages of liver dysfunction alongside traditional liver markers such as aspartate aminotransferase (AST) and cytokeratin-18 (CK18) [37,39,43]. The gene discussed is KRT18; the disease is Decreased liver function.